Traws Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Traws Pharma (TRAW).

Price Target Range — 3 Quarters

Analyst Consensus — 2 Analysts

2Hold

Consensus RatingNeutral# Analysts2Avg. Consensus PT$1Upside to Avg. PT+225.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 18, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Neutral	$1
Jun 18, 2026	HC Wainwright & Co.	Brandon Folkes	Downgrade	Buy→Neutral	$1
Jun 15, 2026	Ladenburg Thalmann	Kevin DeGeeter	Downgrade	Buy→Neutral	—
May 20, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$8
Dec 3, 2025	HC Wainwright & Co.	Brandon Folkes	Initiate	Buy	$8

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Neutral on Traws Pharma, Maintains $1 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Traws Pharma (NASDAQ:TRAW) with a Neutral and maintains $1 price target.

Benzinga Newsdesk

This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Wall Street analysts updated ratings for CURB, INTU, ENGN. See their outlooks and targets at Benzinga's analyst ratings page.

Avi Kapoor

PRO
HC Wainwright & Co. Downgrades Traws Pharma to Neutral, Announces $1 Price Target

HC Wainwright & Co. analyst Brandon Folkes downgrades Traws Pharma (NASDAQ:TRAW) from Buy to Neutral and announces $1 price target.

Benzinga Newsdesk

PRO
Ladenburg Thalmann Downgrades Traws Pharma to Neutral

Ladenburg Thalmann analyst Kevin DeGeeter downgrades Traws Pharma (NASDAQ:TRAW) from Buy to Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Traws Pharma, Maintains $8 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Traws Pharma (NASDAQ:TRAW) with a Buy and maintains $8 price target.

Benzinga Newsdesk

This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Traws Pharma Inc

Traws Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Neutral on Traws Pharma, Maintains $1 Price Target

This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

PRO
HC Wainwright & Co. Downgrades Traws Pharma to Neutral, Announces $1 Price Target

PRO
Ladenburg Thalmann Downgrades Traws Pharma to Neutral

PRO
HC Wainwright & Co. Reiterates Buy on Traws Pharma, Maintains $8 Price Target

This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

People Also Watch

People Also Watch

Traws Pharma Inc

Traws Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Neutral on Traws Pharma, Maintains $1 Price Target

This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

PROHC Wainwright & Co. Downgrades Traws Pharma to Neutral, Announces $1 Price Target

PROLadenburg Thalmann Downgrades Traws Pharma to Neutral

PROHC Wainwright & Co. Reiterates Buy on Traws Pharma, Maintains $8 Price Target

This Linde Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Neutral on Traws Pharma, Maintains $1 Price Target

PRO
HC Wainwright & Co. Downgrades Traws Pharma to Neutral, Announces $1 Price Target

PRO
Ladenburg Thalmann Downgrades Traws Pharma to Neutral

PRO
HC Wainwright & Co. Reiterates Buy on Traws Pharma, Maintains $8 Price Target